Medtronic Plc (MDT)

101.43
0.63 0.63
NYSE : Health Technology
Prev Close 100.80
Open 101.12
Day Low/High 100.96 / 101.86
52 Wk Low/High 81.66 / 102.74
Volume 1.99M
Avg Volume 4.88M
Exchange NYSE
Shares Outstanding 1.34B
Market Cap 135.91B
EPS 3.40
P/E Ratio 29.72
Div & Yield 2.16 (1.98%)

Latest News

Medtronic Announces The Early Results Of Its Cash Tender Offers For Up To $5.525 Billion Of Certain Outstanding Debt Securities Issued By Medtronic, Inc., Medtronic Global Holdings S.C.A. And Covidien International Finance S.A.

Medtronic Announces The Early Results Of Its Cash Tender Offers For Up To $5.525 Billion Of Certain Outstanding Debt Securities Issued By Medtronic, Inc., Medtronic Global Holdings S.C.A. And Covidien International Finance S.A.

DUBLIN, July 10, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (the "Company") (NYSE:MDT) today announced that, pursuant to the previously announced cash tender offers (collectively, the "Tender Offers") by its wholly-owned indirect subsidiaries, Medtronic, Inc.

Medtronic HeartWare(TM) HVAD(TM) Implanted Via Less Invasive Thoracotomy Shows 95 Percent Freedom From Disabling Stroke At Two Years

Medtronic HeartWare(TM) HVAD(TM) Implanted Via Less Invasive Thoracotomy Shows 95 Percent Freedom From Disabling Stroke At Two Years

Company Plans Global Registry of HVAD Thoracotomy Implants to Advance Therapy Knowledge

Medtronic Announces Closing Of Public Offering Of €5 Billion Of Senior Notes

Medtronic Announces Closing Of Public Offering Of €5 Billion Of Senior Notes

DUBLIN, July 02, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (the "Company") (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.

Amgen's Rally Could Just Be Getting Started

Amgen's Rally Could Just Be Getting Started

Amgen shares have rallied in recent years. Dividend growth names like Amgen remain attractive in a low-yield environment. Healthcare will likely continue in the headlines.

Dexcom Looks Like It Can Finally Break Out on the Topside

Dexcom Looks Like It Can Finally Break Out on the Topside

Let's check the charts and indicators on the glucose-monitoring company.

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

Jim Cramer looks at retail, specifically the companies that are doing well for working-class Americans, and those that cater to high-end customers -- a 'barbell economy,' he says.

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.

Medtronic Is Edging Closer to an Upside Breakout on the Charts

Medtronic Is Edging Closer to an Upside Breakout on the Charts

No one knows their business as well as the CEO.

We're in Bizarro Land: Cramer's 'Mad Money' Recap (Wednesday 6/5/19)

We're in Bizarro Land: Cramer's 'Mad Money' Recap (Wednesday 6/5/19)

Investors should consider recession-proof names in the current environment, Jim Cramer says.

Medtronic Gains on Strong Fourth-Quarter Earnings

Medtronic Gains on Strong Fourth-Quarter Earnings

Shares of health device and equipment maker Medtronic rise after the company reports fiscal fourth-quarter and full-year earnings in line with analysts' forecasts, and offers an upbeat assessment of its prospects for fiscal 2020.

Trade War Heats Up, Fundamental Analysis, Boeing on the Hot Seat: Market Recon

Trade War Heats Up, Fundamental Analysis, Boeing on the Hot Seat: Market Recon

China's President Xi has obviously found surrender distasteful.

Tech Trade War, Best Buy, Tyson Foods, L Brands, Boeing - 5 Things You Must Know

Tech Trade War, Best Buy, Tyson Foods, L Brands, Boeing - 5 Things You Must Know

U.S. stock futures point lower and global stocks decline as the U.S.-China trade dispute intensifies; Apple and Tesla extend declines amid worries of a damaging tech cold war; Tyson Foods is looking to set up a beef-processing plant in Kazakhstan to avoid Chinese tariffs, a report says; L Brands soars after lifting its earnings guidance.

Medtronic Expected to Earn $1.46 a Share

Medtronic Expected to Earn $1.46 a Share

Medtronic revenue expected to fall 0.4% to $8.1 billion.

Medtronic Moves Up In Analyst Rankings, Passing KLA-Tencor

Medtronic Moves Up In Analyst Rankings, Passing KLA-Tencor

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Medtronic PLC has taken over the #156 spot from KLA-Tencor Corp , according to ETF Channel. Below is a chart of Medtronic PLC versus KLA-Tencor Corp plotting their respective rank within the S&P 500 over time (MDT plotted in blue; KLAC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

In Lull Between Earnings Seasons, Keep an Eye on Data and Insider Selling

A key data point to watch, now that corporate blackout dates have come and gone, is insider selling activity.

In Lull Between Earnings Seasons, Keep an Eye on Data and Insider Selling

A key data point to watch, now that corporate blackout dates have come and gone, is insider selling activity.

A Technical Strategy for Tandem Diabetes Care

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Jim Cramer has your game plan for next week: Keep a sharp eye out for the Fed and the employment data.

Dow Closes Higher as Wall Street Looks to Next Round of Trade Talks

Dow Closes Higher as Wall Street Looks to Next Round of Trade Talks

Stocks edger higher Tuesday as investors look to a key round of trade talks between the U.S. and China.

Medtronic Reports Strong Surgical Product Sales on Way to Earnings Beat

Medtronic Reports Strong Surgical Product Sales on Way to Earnings Beat

Medtronic raises its full-year earnings forecast above analysts' estimates.

Walmart, Southwest, Honda, HSBC and Trade Talks - 5 Things You Must Know

Walmart, Southwest, Honda, HSBC and Trade Talks - 5 Things You Must Know

U.S. stock futures decline slightly as investors look to the next round of trade talks between the U.S. and China; Walmart, the world's largest retailer, reports earnings Tuesday; the FAA is probing Southwest over baggage weight discrepancies, a report says; Honda will close its plant in Britain.

Medtronic Expected to Earn $1.24 a Share

Medtronic Expected to Earn $1.24 a Share

Medtronic revenue seen rising in latest quarter to $7.5 billion.

Don't Underestimate a Trade Deal: Cramer's 'Mad Money' Recap (Friday 02/15/19)

Don't Underestimate a Trade Deal: Cramer's 'Mad Money' Recap (Friday 02/15/19)

Don't underestimate how positive an actual trade deal with China would be for American companies, Jim Cramer argues.

How to Fatten Up Your Portfolio By Investing in the Obesity Epidemic

How to Fatten Up Your Portfolio By Investing in the Obesity Epidemic

As the U.S. and the world grow fatter, some investors are seeing green as they bulk up on stocks of companies on the front-lines of this 21st century Battle of the Bulge.

Real Money Post-Industrial Average Shines in January, Outperforming S&P 500

Real Money Post-Industrial Average Shines in January, Outperforming S&P 500

RMPIA soared 9.9% for the month, led by 11 double-digit gainers.

Medtronic Stock Is Showing Promise on the Daily Chart

Medtronic Stock Is Showing Promise on the Daily Chart

Here's how to trade MDT, going long.

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.

TheStreet Quant Rating: A (Buy)